Stockreport

NeuroSense: PrimeC Produces Statistically Significant Reductions in Alzheimer's Disease Biomarkers [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today announced new positive findings based on plasma samples from its Pha [Read more]